Boston Scientific (BSX) has agreed to make an undisclosed, one-time payment to OrbusNeich to settle all stent-based litigation. This includes settling lawsuits in the United States, the Netherlands, Ireland, Germany and the UK. OrbusNeich is a vascular medical devices company with headquarters in Hong Kong and U.S. offices in Ft. Lauderdale, Fla. In May, OrbusNeich […]
A Massachusetts federal judge ruled that two non-patent claims in OrbusNeich Medical Inc.’s infringement lawsuit over Boston Scientific Corp.’s (NYSE:BSX) Liberté stent should not be dismissed for being too old. Judge Richard Stearns of the U.S. District Court for Massachusetts denied Natick, Mass.-based Boston Scientific’s motion for a summary judgment on OrbusNeich’s claims for breach […]
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
OrbusNeich Medical Inc. wasted no time after winning a new patent from the U.S. Patent & Trademark Office, filing a motion to amend a patent infringement lawsuit against Boston Scientific Corp. (NYSE:BSX) to include its new intellectual property. The USPTO granted the Hong Kong-based firm, which has its U.S. headquarters in Ft. Lauderdale, Fla., a […]